Get started
NOVAVAX INCNOVAVAX INCNOVAVAX INC

NOVAVAX INC

No trades
See on Supercharts
Overview Financials News
Ideas
Discussions Technicals Forecast Seasonals Bonds

NVAX trade ideas

NVAX coronavirus panic.NVAX coronavirus panic. Currently, several biotech shares rose significantly yesterday. The driving force is a fundamental fear of the coronavirus. NVAX is one of the potential candidates who can isolate and solve the problem. The fair value of NVAX stock is currently around USD 11.5. Technically, the stock price is in the right place. But what about panic? Is technology down there? ... Not sure. With braver target prices, the next upswing can be exploited. Let's start with the most basic target price rule. The target price is the sum of the closing value of the given trading time frame and the ATR of the two farthest moving averages measured at the closing values. Where can we be brave here? There to raise the timeframe to W1. In this timeframe, we generate a closing value ATR and this can give you a target price level. So if we calculate a target price using W1 ATR calculation, then the target price can be 33.6usd. A 231% increase from the current level. This analysis is highly speculative. But in panic it can easily work.
NASDAQ:NVAX
by meszaros
24
NVAX Bullish PennantThese are my thoughts and positions, 1. Appears that NVAX has opportunity for breakout as pennant matures 2. Price is trending healthily above 200 EMA.Price is also above and respecting the 50 EMA like they're in a long term committed relationship celebrating Valentine's day. 3. Notice the mid term higher lows signifying bullish strength 4.Support market structure at $2.10 -2.20 is displaying strength. 5. Profit Target One $4.2, Stop-Loss $1.47 6. Bullish on NVAX and mid to long term trend continuation.
NASDAQ:NVAX
by Michael-David
NVAX impulse wave is expected...NVAX impulse wave is expected. Based on W1 technical analysis, a very significant impulse wave may develop in the exchange rate. The pulse amplitude can reach 6 usd levels. As we have shaped our strategy for this impulse, we are moving along this. The correction of the resulting pulse wave correction is expected to be 5.66 usd. The yellow rectangular movement is lateral, followed by an increase. The second strong rising wave, albeit momentum, is far below the pulse wave characteristics. The acceleration of movement is indicated by the steeper ATR axis (purple line). The second target rate may be around 10 usd levels.
NASDAQ:NVAXLong
by meszaros
10
Novavax (NVAX): a super-risky investment value propositionWhile Novavax has some positives, it is not a good candidate for new money. Novavax's two marquee programs, RSV F for maternal vaccination and NanoFlu are not doing particularly well, as they are getting delayed. RSV F for maternal vaccination is now in Phase 3, but many investors are wondering if it's a viable drug. Even if Novavax successfully meets the development challenges, it may face strong competition from other biotech companies. One possibility for Novovax is to be bought out, in which case the stock may be underpriced. www.finstead.com
NASDAQ:NVAX
by GmmaTech